09 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/09/2859900/0/en/Qualigen-Therapeutics-Announces-Poster-Featuring-Positive-Early-Clinical-Experience-with-QN-302-a-Novel-First-in-Class-G-Quadruplex-Experimental-Anti-Cancer-Drug-at-the-American-As.html
LOOKING FOR A SUPPLIER?